At Stream Bio, we develop and manufacture a range of innovative bioimaging molecular probes that cover the visible and near infra-red spectrum, Conjugated Polymer Nanoparticles (CPNs™), for applications in R&D, in-vitro diagnostic assay’s and therapeutic research. CPN’s have superior properties to conventional probes such as an intense brightness (sensitivity), incredible stability (temperature and pH) and can be linked to a variety of targeting molecules.
Invented in the research labs of King’s College London, Stream Bio was founded as the vehicle through which to demonstrate the wide-ranging benefits and applications of CPNs™. Our approach combines a forward-thinking attitude with a breadth of industry expertise in both science and business, enabling us to create CPN™ solutions for the various strands of the life science industry. In the not too distant future, it is expected that Stream’s technology will positively impact in vivo R&D, diagnostics and therapeutics.